An Overview of Thrombophilia and Associated Laboratory Testing.
Venous thromboembolism, usually entailing deep vein thrombosis, pulmonary embolism, or both, is a complex and multifactorial disorder, in which a number of putative conditions interplay and finally contribute to propel the individual risk over a certain degree, so ultimately culminating in the development of venous occlusive disorders. Thrombophilia is commonly defined as a propensity to develop venous thromboembolism on the basis of an underlying hypercoagulable state attributable to inherited or acquired disorders of blood coagulation or fibrinolysis. The thrombophilic conditions are conventionally classified as inherited (or genetically determined) and acquired. The former include deficiencies of natural anticoagulants such as antithrombin, protein C, protein S, increased values of clotting factors (especially factor VIII), as well as prothrombotic polymorphisms in genes encoding for factor V (i.e., factor V Leiden) and prothrombin. The latter conditions mainly entail antiphospholipid antibody syndrome, malignancy, acquired elevations of coagulation factors or acquired reduction of natural inhibitors, or hyperhomocysteinemia. Deepened knowledge of all potential risk factors, as well as the clear understanding of their role in the pathophysiology of venous thrombosis, are both essential to help achieve a faster and more efficient diagnosis of this condition as well as a more effective prophylaxis of patients at higher risk and treatment of those with manifest disease.
['Montagnana|Martina|M|', 'Lippi|Giuseppe|G|', 'Danese|Elisa|E|']
D000818:Animals D016736:Antiphospholipid Syndrome D001777:Blood Coagulation D005165:Factor V D020138:Hyperhomocysteinemia D008232:Lymphoproliferative Disorders D009196:Myeloproliferative Disorders D009369:Neoplasms D011110:Polymorphism, Genetic D011516:Prothrombin D012307:Risk Factors D019851:Thrombophilia
Thrombophilia Factor V Leiden Antiphospholipid antibody syndrome Thrombophilic risk factors VTE